Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances

We evaluated the efficacy of terodiline hydrochloride (TD-758) in 23 patients with psychosomatic bladder, chronic prostatitis and chronic cystitis. The drug was administered at a dose of 24 mg once a day for 4 weeks. In 78% of the patients the symptoms such as urinary frequency and sense of residual...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 34(1988), 1 vom: 15. Jan., Seite 196-200
1. Verfasser: Nakano, M (VerfasserIn)
Weitere Verfasser: Tajima, A, Aso, Y, Suzuki, K, Hata, M, Tsukada, T, Masuda, H, Hirose, J, Kitagawa, M, Nakahara, M
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1988
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Butylamines Calcium Channel Blockers terodiline 70KG06964W
LEADER 01000naa a22002652 4500
001 NLM03358074X
003 DE-627
005 20231221124906.0
007 tu
008 231221s1988 xx ||||| 00| ||jpn c
028 5 2 |a pubmed24n0112.xml 
035 |a (DE-627)NLM03358074X 
035 |a (NLM)3376801 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Nakano, M  |e verfasserin  |4 aut 
245 1 0 |a Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances 
264 1 |c 1988 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 24.06.1988 
500 |a Date Revised 15.11.2012 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a We evaluated the efficacy of terodiline hydrochloride (TD-758) in 23 patients with psychosomatic bladder, chronic prostatitis and chronic cystitis. The drug was administered at a dose of 24 mg once a day for 4 weeks. In 78% of the patients the symptoms such as urinary frequency and sense of residual urine improved. Only mild side effects such as thirst were noted. We concluded that terodiline hydrochloride was effective in this trial 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Butylamines  |2 NLM 
650 7 |a Calcium Channel Blockers  |2 NLM 
650 7 |a terodiline  |2 NLM 
650 7 |a 70KG06964W  |2 NLM 
700 1 |a Tajima, A  |e verfasserin  |4 aut 
700 1 |a Aso, Y  |e verfasserin  |4 aut 
700 1 |a Suzuki, K  |e verfasserin  |4 aut 
700 1 |a Hata, M  |e verfasserin  |4 aut 
700 1 |a Tsukada, T  |e verfasserin  |4 aut 
700 1 |a Masuda, H  |e verfasserin  |4 aut 
700 1 |a Hirose, J  |e verfasserin  |4 aut 
700 1 |a Kitagawa, M  |e verfasserin  |4 aut 
700 1 |a Nakahara, M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 34(1988), 1 vom: 15. Jan., Seite 196-200  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnns 
773 1 8 |g volume:34  |g year:1988  |g number:1  |g day:15  |g month:01  |g pages:196-200 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 34  |j 1988  |e 1  |b 15  |c 01  |h 196-200